Funding

Vivere Oncotherapies

United States · Biotech · Healthtech

Vivere Oncotherapies develops cancer treatments designed to activate immune recognition and destruction of cancer cells.

Visit viveretx.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A$10MBerkeley Frontier Fund — Role not disclosedFreeflow Ventures — Role not disclosedPillar — Role not disclosedThe National Cancer Institute — Role not disclosedYK Bioventures — Role not disclosed

Investors

Berkeley Frontier FundSeries AFreeflow VenturesSeries APillarSeries AThe National Cancer InstituteSeries AYK BioventuresSeries A

Coverage

Jan 13, 2026Vivere Oncotherapies · Series A

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcesprojectstartups.com ↗